Lux Capital

Venture fund

Stages: Seed, Series A, Series B
Cheque size: $2M to $50M
Based in: United States
Focus: Devices & Robotics, Pharma & Drug Discovery, Imaging & Diagnostics

Lux Capital is a New York based venture firm founded in 2000 by Josh Wolfe, Peter Hebert and Robert Paull, investing in emerging science and technology from artificial intelligence to robotics and biotech. It manages several billion dollars and backs health related ventures alongside deep technology.

Invests at the frontier of science and engineering, including hard health technology.

Notable investments

Recursion
Hyperfine
Osmind

Firm website

The journey

How Lux Capital got here, step by step.

2000
Firm founded
Josh Wolfe, Peter Hebert and Robert Paull founded Lux Capital in New York to back emerging technology companies.
2000s
Early deep technology and biotech bets
Lux built a reputation investing where science, hard technology and biotechnology meet.
2010s
Fund sizes expand
Successive funds grew assets under management, supporting later stage technology and biotech investments.
2015
Auris Health investment
Lux backed the surgical robotics company Auris Health, later acquired by Johnson and Johnson.
2021
Assets reach billions
Assets under management grew to roughly seven billion dollars across technology and life sciences.
2020s
Continued health technology backing
The firm continues supporting health and biotech ventures alongside its wider deep technology portfolio.